A single vaccine has been developed to protect against both the Ebola virus and rabies by researchers from several institutions including Thomas Jefferson University and the National Institute of Allergy and Infectious Diseases.
The Journal of Virology published the findings on their website on August 17.
The vaccine has been tested successfully on mice. Considering that it surpasses other Ebola vaccines, it should be easy to speed up its development for use in primates and humans. According to researchers, the vaccine is built on the same foundations as the rabies vaccine, which is financially viable and has already been approved. As it protects against two viruses rather than just one, the vaccine could prove to be the ideal public health tool.